Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Klapötke

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biology of Metals|January 1, 1988
Biological activity of organometallic bismuth compoundsT Klapötke
Cancer Chemotherapy and Pharmacology|January 1, 1992
Ionic rhenocene derivatives with antitumor activityP Köpf-Maier, T Klapötke
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation statesP Köpf-Maier, T Klapötke
Arzneimittel-Forschung|March 1, 1989
Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumorsP Köpf-Maier, T Klapötke
Arzneimittel-Forschung|April 1, 1989
Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumorsP Köpf-Maier, T Klapötke
Cancer Chemotherapy and Pharmacology|January 1, 1989
Ionic titanocene complexes: a new type of antitumor agentP Köpf-Maier, E Neuse, T Klapötke, et al.
Anticancer Research|January 1, 1986
Tumor inhibition by titanocene complexes: activity against sarcoma 180P Köpf-Maier, F Preiss, T Marx, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biology of Metals|January 1, 1988
Biological activity of organometallic bismuth compoundsT Klapötke
Cancer Chemotherapy and Pharmacology|January 1, 1992
Ionic rhenocene derivatives with antitumor activityP Köpf-Maier, T Klapötke
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation statesP Köpf-Maier, T Klapötke
Arzneimittel-Forschung|March 1, 1989
Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumorsP Köpf-Maier, T Klapötke
Arzneimittel-Forschung|April 1, 1989
Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumorsP Köpf-Maier, T Klapötke
Cancer Chemotherapy and Pharmacology|January 1, 1989
Ionic titanocene complexes: a new type of antitumor agentP Köpf-Maier, E Neuse, T Klapötke, et al.
Anticancer Research|January 1, 1986
Tumor inhibition by titanocene complexes: activity against sarcoma 180P Köpf-Maier, F Preiss, T Marx, et al.
Pageof 1